Atea Pharmaceuticals Inc. Revenue 2020–2021
Atea Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2020 to 2021. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Atea Pharmaceuticals Inc. revenue for the quarter ending September 30, 2021 was 32.8 M.
- Atea Pharmaceuticals Inc. annual revenue for 2021 was 351.4 M, a 622.49% increase from 2020.
- Atea Pharmaceuticals Inc. annual revenue for 2020 was 48.6 M.
Atea Pharmaceuticals Inc. (AVIR) — Frequently Asked Questions
Atea Pharmaceuticals Inc. (AVIR) is a publicly traded US company. It has a market capitalization of $387M. In fiscal 2021 it reported revenue of $351M and net income of $121M. Explore AVIR's stock price, financial statements, earnings history, margins and key ratios below.
What is Atea Pharmaceuticals Inc.'s market cap?
Atea Pharmaceuticals Inc. (AVIR) has a market capitalization of $387M.
What is the AVIR stock price?
AVIR trades at $4.39 (+0.69% on the day).
How much revenue does Atea Pharmaceuticals Inc. make?
Atea Pharmaceuticals Inc. reported revenue of $351M in fiscal 2021.
Is AVIR profitable?
In fiscal 2021, Atea Pharmaceuticals Inc. reported net income of $121M.